DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
1-Year Est. Return
13.6%
1 Year Est. Return
+13.6%
AUM
$3.09B
AUM Growth
+$421M
(+16%)
Holding
78
Top Buys
| 1 | +$96.7M | |
| 2 | +$79.4M | |
| 3 | +$76.2M | |
| 4 |
Akero Therapeutics
AKRO
|
+$69.6M |
| 5 |
BridgeBio Pharma
BBIO
|
+$68.5M |
Top Sells
| 1 | +$125M | |
| 2 | +$49.9M | |
| 3 | +$42.4M | |
| 4 |
Genmab
GMAB
|
+$41.7M |
| 5 |
Guardant Health
GH
|
+$41.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $264M | 8.54% |
2,000,000
|
|
||
|
2
Guardant Health
GH
$8.19B
| $232M | 7.51% |
5,443,721
-975,845
|
|
||
3
Dynavax Technologies
DVAX
$1.16B
| $231M | 7.47% |
17,791,486
|
|
||
4
Immunovant
IMVT
$2.99B
| $162M | 5.26% |
9,500,000
+3,500,000
|
|
||
5
Protagonist Therapeutics
PTGX
$4.78B
| $145M | 4.7% |
3,000,000
+2,000,000
|
|
||
6
Ionis Pharmaceuticals
IONS
$11.6B
| $138M | 4.46% |
4,564,207
+2,630,279
|
|
||
|
7
Akero Therapeutics
AKRO
$4.3B
| $130M | 4.21% |
3,210,270
+1,720,270
|
|
||
8
Cytokinetics
CYTK
$7.05B
| $124M | 4% |
3,073,853
+573,853
|
|
||
9
Apellis Pharmaceuticals
APLS
$3.09B
| $109M | 3.54% |
5,000,000
+725,079
|
|
||
10
Ocular Therapeutix
OCUL
$2.48B
| $105M | 3.39% |
14,294,420
+1,458,138
|
|
||
|
11
BridgeBio Pharma
BBIO
$10.4B
| $96.8M | 3.13% |
2,800,000
+1,980,838
|
|
||
12
Tarsus Pharmaceuticals
TARS
$3.12B
| $76.2M | 2.47% |
+1,484,266
|
|
||
13
Viridian Therapeutics
VRDN
$1.95B
| $72.5M | 2.35% |
5,380,449
+857,708
|
|
||
14
Structure Therapeutics
GPCR
$1.6B
| $71M | 2.3% |
4,100,000
+1,300,000
|
|
||
15
89bio
ETNB
$2.19B
| $67.7M | 2.19% |
9,316,333
+2,838,084
|
|
||
16
Nurix Therapeutics
NRIX
$755M
| $65.3M | 2.12% |
5,500,000
+2,500,000
|
|
||
17
Geron
GERN
$766M
| $60.7M | 1.97% |
38,176,251
+34,164,964
|
|
||
18
Sarepta Therapeutics
SRPT
$2.34B
| $57.4M | 1.86% |
+899,731
|
|
||
19
Ultragenyx Pharmaceutical
RARE
$3.2B
| $48.9M | 1.58% |
1,350,000
+696,487
|
|
||
20
ANI Pharmaceuticals
ANIP
$2.08B
| $46.9M | 1.52% |
700,000
+50,958
|
|
||
21
Dianthus Therapeutics
DNTH
$1.42B
| $42.8M | 1.38% |
+2,357,702
|
|
||
22
Immunocore
IMCR
$1.69B
| $41.9M | 1.36% |
1,411,402
+892,026
|
|
||
23
Celldex Therapeutics
CLDX
$1.76B
| $36.3M | 1.18% |
2,000,000
+459,868
|
|
||
|
MAZE
24
Maze Therapeutics
MAZE
$1.22B
| $36M | 1.17% |
+3,269,126
|
|
||
25
Amgen
AMGN
$159B
| $35.2M | 1.14% |
+113,035
|
|